The latest news on generic drugs
But experts add that painkiller's other health benefits may outweigh possible link
Long approval times, brand-company deals, and biologics impasse slow supply of new generics.
Daily aspirin appears not to improve the odds for people with very early peripheral artery disease.
Experts pick a dozen stocks set to benefit from the influx of boomers.
Aspirin may be right for the heart and wrong for the GI tract.
Close is not good enough as lookalikes to expensive medicines can offer unsafe variations.
Families with incomes up to $105,000 can benefit from cheaper medicines.
The choices include generics, medium-potency statins, and high-powered Lipitor and Crestor.